FDA review finds no action needed at Balchem, LLC after Feb. 4 inspection in Sleepy Eye

Martin A. Makary, M.D. Commissioner of Food and Drugs of FDA
Martin A. Makary, M.D. Commissioner of Food and Drugs of FDA
0Comments

An inspection by the Food and Drug Administration at Balchem, LLC in Sleepy Eye on Feb. 4 focused on identifying foodborne biological hazards, as shown in data provided on the FDA’s website.

The final report stated no corrective actions were required regarding the company’s management practices.

The FDA carries out routine inspections of facilities nationwide to ensure workplaces and products adhere to FDA regulations designed to safeguard public health. Outcomes of these inspections are made publicly available.

The agency’s website states that the FDA oversees the safety and quality of human and animal drugs, biological goods, medical devices, and tobacco products.

Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.



Related

Dr. Mehmet Oz CMS Administrator

Gaithersburg Medicaid billing for Medicine Services and Procedures reaches $12.4M in 2024

In 2024, Medicaid providers in Gaithersburg submitted $12,389,106 in claims for the Medicine Services and Procedures category, marking an 8.4% increase over the prior year.

Dr. Mehmet Oz CMS Administrator

Rockville Medicaid payments for Radiology Procedures total $9,162,283 in 2024

Medicaid reimbursements for Radiology Procedures in Rockville grew by 3.3% in 2024, highlighting shifts in service volume and reimbursement trends.

Arlington National Cemetery, Virginia

Montgomery County service members remembered this week ending June 6 for their sacrifice in war

Service members from Montgomery County are remembered this week ending June 6 for their sacrifice during wartime.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from Montgomery News.